Effects of glaucoma on the therapeutic effects of anti-vascular endothelial growth factor agents on macular edema associated with retinal vein branch occlusion

Effects of glaucoma on the therapeutic effects of anti-vascular endothelial growth factor agents on macular edema associated with retinal vein branch occlusion - Effects of glaucoma on on macular edema associated with retinal vein branch occlusion

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000037679

Enrollment

100

Registered

2019-08-13

Start date

2019-04-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

macular edema associated with retinal vein branch occlusion

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Visual disturbance due to center involved ME(evaluated using OCT)treated with anti-VEGF agents 2)BCVA(pre-treatment) is over 24 letters(20/320) 3)CRT>300 micro meter 4)Over 12 month followup after treatment.

Exclusion criteria

Exclusion criteria: 1)Ocular diseases other than BRVO-ME 2)Severe general complications 3)Those who inappropriate

Design outcomes

Primary

Measure	Time frame
The change of central retina thicknes	—

Countries

Japan

Contacts

Public ContactMasahiko Sugimoto

Mie University Graduate School of Medicine Department of Ophthalmology

sugmochi@clin.medic.mie-u.ac.jp0592315027

Outcome results